carmustine has been researched along with piperidines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockman, RW; Laster, WR; Schabel, FM; Shaddix, SC; Trader, MW | 1 |
| Bible, KC; Kaufmann, SH | 1 |
| Anderl, KL; Bartelt, D; Bible, KC; Boerner, SA; Eckdahl, S; Jenkins, RB; Kaufmann, SH; Kirkland, K; Kottke, TJ; Lee, YK; Stalboerger, PG; Svingen, PA | 1 |
3 other study(ies) available for carmustine and piperidines
| Article | Year |
|---|---|
Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Topics: Animals; Antibiotics, Antineoplastic; Carmustine; Cells, Cultured; Cyclophosphamide; DNA, Neoplasm; Dose-Response Relationship, Drug; Leukemia L1210; Melphalan; Mice; Piperazines; Piperidines | 1976 |
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carmustine; Cisplatin; Cyclin-Dependent Kinases; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Synergism; Etoposide; Flavonoids; Fluorouracil; Humans; Lung Neoplasms; Paclitaxel; Piperidines; Tumor Stem Cell Assay | 1997 |
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
Topics: Antineoplastic Agents; Carmustine; Chromosome Aberrations; Chromosome Mapping; Cisplatin; DNA Adducts; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Karyotyping; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Piperidines; Tumor Cells, Cultured | 2000 |